Buscador de publicacions


  • Cereijo R, Taxerås SD, Piquer-Garcia I, Pellitero S, Martínez Franco E, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Jiménez-Pavón D, Lerin C, Villarroya-Gombau F and Sánchez-Infantes D.

    Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery.

    OBESITY SURGERY . 30(1): 174-179. Nº de cites: 8


  • Jimenez-Pavon D, Corral-Perez J, Sánchez-Infantes D, Villarroya-Gombau F, Ruiz JR and Martinez-Tellez B.

    Infrared Thermography for Estimating Supraclavicular Skin Temperature and BAT Activity in Humans: A Systematic Review.

    Obesity . 27(12): 1932-1949.


  • Villarroya-Terrade J, Cereijo R, Gavaldà-Navarro A, Peyrou M, Giralt M and Villarroya-Gombau F.

    New insights into the secretory functions of brown adipose tissue.

    J ENDOCRINOL . 243(2): .


  • Quesada T, Gavaldà-Navarro A, Morón S, Campderrós L, Iglesias R, Giralt M and Villarroya-Gombau F.

    GPR120 controls neonatal brown adipose tissue thermogenic induction.

    AM J PHYSIOL-ENDOC M . 317(5): . Nº de cites: 7


  • Campderrós L, Moure R, Cairo M, Gavaldà-Navarro A, Quesada T, Cereijo R, Giralt M, Villarroya-Terrade J and Villarroya-Gombau F.

    Brown Adipocytes Secrete GDF15 in Response to Thermogenic Activation.

    Obesity . 27(10): 1606-1616. Nº de cites: 38


  • Casasnovas C, Ruiz M, Schlüter A, Naudí A, Fourcade S, Veciana M, Castañer S, Albertí A, Bargalló N, Johnson M, Raymond GV, Fatemi A, Moser AB, Villarroya-Gombau F, Portero-Otín M, Artuch-Iriberri R, Pamplona R and Pujol A.

    Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

    neurotherapeutics : the journal of the american society for experimental neurotherapeutics . 16(4): 1167-1182.


  • Zarei M, Pujol E, Quesada T, Villarroya-Gombau F, Barroso E, Vázquez S, Pizarro J, Palomer FX and Vazquez M.

    Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

    BRITISH JOURNAL OF PHARMACOLOGY . 176(13): 2292-2305. Nº de cites: 7


  • Cairo M, Campderrós L, Gavaldà-Navarro A, Cereijo R, Delgado-Anglés A, Quesada T, Giralt M, Villarroya-Terrade J and Villarroya-Gombau F.

    Parkin controls brown adipose tissue plasticity in response to adaptive thermogenesis.

    EMBO REP . 20(5): . Nº de cites: 17


  • Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya-Gombau F, Fernández-Solà J and Planavila A.

    Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

    JOURNAL OF PATHOLOGY . 248(1): 30-40. Nº de cites: 20


  • Villarroya-Terrade J, Cereijo R, Giralt M and Villarroya-Gombau F.

    Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation.

    FRONTIERS IN PHYSIOLOGY . 10: 67-67. Nº de cites: 12